These are not the only analyst impact calls, but these are the top research notes that a673b.bigscoots-temp.com is focusing on:
Adobe Systems (ADBE) raised to Buy at Deutsche Bank.
Cirrus Logic (CRUS) raised to Buy at Jefferies.
DaVita (DVA) raised to Buy at Oppenheimer.
Embarq (EQ) raised to Overweight at J.P.Morgan.
Equity Residential (EQR) raised to Overweight at Lehman.
International Paper (IP) raised to Outperform at Credit Suisse.
Lincare (LNCR) downgraded to Neutral at Oppenheimer.
Royal Gold (RGLD) raised to Overweight at HSBC.
Windstream (WIN) downgraded to Underweight at J.P.Morgan.
BANC OF AMERICA ON DRUGS: Barr Pharma (BRL) started as Buy; Multi-Fineline (MFLX) started as Buy; Mylan Labs (MYL) started as Buy; Teva Pharma (TEVA) started as Buy; Watson Pharma (WPI) started as neutral; ZymoGenetics (ZGEN) downgraded to Neutral.
Jon C. Ogg December 18, 2007
Jon Ogg can be reached at [email protected]; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.
If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.